Argos Therapeutics (ARGS) - my price target is $19-$13

Below is my valuation model with assumptions – 

This is their 12 month chart -

This is their Phase3 ADAPT trial design -

Disclosure - ARGS is a holding of my Marketocracy Fund.
I do not short stocks.